Search research articles
Contact Us
Filters
Showing results (1-10 of 25) with videos related to
Page
of 3
Sort By:
Muscle & Nerve
|
February 7, 2026
Safety of Intravenous Edaravone in Clinical Practice
Angela Genge, Stephen Apple
Muscle & Nerve
|
February 7, 2026
Introduction to the Supplement
Kelly G Gwathmey, Stephen Apple
Muscle & Nerve
|
February 7, 2026
Current and Ongoing Clinical Studies
Agessandro Abrahao, Lorne Zinman, Stephen Apple
Muscle & Nerve
|
February 7, 2026
Study 19 (MCI186-19) Post Hoc Analyses
Benjamin Rix Brooks, Jeremy Shefner, Stephen Apple
Clinical Pharmacology in Drug Development
|
September 28, 2022
Pharmacokinetics, Bioavailability, and Swallowing Safety With Riluzole Oral Film
James Wymer, Stephen Apple, Antoinette Harrison, et al.
Muscle & Nerve
|
February 7, 2026
Generalizability of Edaravone Efficacy
Benjamin Rix Brooks, David L Ennist, Danielle Beaulieu, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
August 26, 2020
Engaging ALS patients and caregivers (the ALS research ambassadors) to help design the REFINE-ALS biomarker study
James D Berry, Richard Bedlack, Debra Mathews, et al.
Journal of the Neurological Sciences
|
November 12, 2024
Efficacy of Radicava® IV (intravenous edaravone) in subjects with differing trajectories of disease progression in amyotrophic lateral sclerosis: Use of a novel statistical approach for post hoc analysis of a pivotal phase 3 clinical trial
Erik P Pioro, Benjamin Rix Brooks, Ying Liu, et al.
Muscle & Nerve
|
August 1, 2023
The effects of intervention with intravenous edaravone in Study 19 on hospitalization, tracheostomy, ventilation, and death in patients with amyotrophic lateral sclerosis
Benjamin Rix Brooks, Erik P Pioro, Takeshi Sakata, et al.
Plos One
|
June 14, 2022
Edaravone efficacy in amyotrophic lateral sclerosis with reduced forced vital capacity: Post-hoc analysis of Study 19 (MCI186-19) [clinical trial NCT01492686]
Benjamin Rix Brooks, Terry Heiman-Patterson, Martina Wiedau-Pazos, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 25) with videos related to
Sort By:
Page
of 3
Muscle & Nerve
|
February 7, 2026
Safety of Intravenous Edaravone in Clinical Practice
Angela Genge, Stephen Apple
Muscle & Nerve
|
February 7, 2026
Introduction to the Supplement
Kelly G Gwathmey, Stephen Apple
Muscle & Nerve
|
February 7, 2026
Current and Ongoing Clinical Studies
Agessandro Abrahao, Lorne Zinman, Stephen Apple
Muscle & Nerve
|
February 7, 2026
Study 19 (MCI186-19) Post Hoc Analyses
Benjamin Rix Brooks, Jeremy Shefner, Stephen Apple
Clinical Pharmacology in Drug Development
|
September 28, 2022
Pharmacokinetics, Bioavailability, and Swallowing Safety With Riluzole Oral Film
James Wymer, Stephen Apple, Antoinette Harrison, et al.
Muscle & Nerve
|
February 7, 2026
Generalizability of Edaravone Efficacy
Benjamin Rix Brooks, David L Ennist, Danielle Beaulieu, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
August 26, 2020
Engaging ALS patients and caregivers (the ALS research ambassadors) to help design the REFINE-ALS biomarker study
James D Berry, Richard Bedlack, Debra Mathews, et al.
Journal of the Neurological Sciences
|
November 12, 2024
Efficacy of Radicava® IV (intravenous edaravone) in subjects with differing trajectories of disease progression in amyotrophic lateral sclerosis: Use of a novel statistical approach for post hoc analysis of a pivotal phase 3 clinical trial
Erik P Pioro, Benjamin Rix Brooks, Ying Liu, et al.
Muscle & Nerve
|
August 1, 2023
The effects of intervention with intravenous edaravone in Study 19 on hospitalization, tracheostomy, ventilation, and death in patients with amyotrophic lateral sclerosis
Benjamin Rix Brooks, Erik P Pioro, Takeshi Sakata, et al.
Plos One
|
June 14, 2022
Edaravone efficacy in amyotrophic lateral sclerosis with reduced forced vital capacity: Post-hoc analysis of Study 19 (MCI186-19) [clinical trial NCT01492686]
Benjamin Rix Brooks, Terry Heiman-Patterson, Martina Wiedau-Pazos, et al.
Page
of 3